Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Eptacog Alfa in Acute Intracerebral Haemorrhage
NCT00266006Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2006
- Primary completion
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of coagulation factor VIIa in intracerebral hemorrhage (ICH), sponsored by Novo Nordisk. Started Jan 2006; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT00266006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266006.